This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Cloxacillin Sodium 2000 mg for injection (2017-01-27)

Starting date:
January 27, 2017
Posting date:
February 3, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-62164

Reason

Out of trend result for potency during stability testing.

Depth of distribution

Wholesaler, retailer, hospitals, pharmacies; Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec, Saskatchewan

Affected products

Cloxacillin Sodium 2000 mg for injection

DIN, NPN, DIN-HIM

DIN 01912410

Dosage form

Sterile Powder

Strength

Cloxacillin Sodium 2000 mg

Lot or serial number

GB7312

Companies

Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA